|Headquarters||Geneva, Switzerland, London, San Francisco and Jersey|
|Products||Venture capital, Growth capital|
|Total assets||€2 billion|
Index Ventures is a venture capital investment firm based in Geneva, Switzerland, with offices in London, Jersey, and starting in 2011, San Francisco. The firm was founded in 1996 by Neil Rimer, David Rimer and Giuseppe Zocco. Since its inception, the firm has raised four main venture funds and a growth capital fund with in excess of €2 billion of investor commitments. Index invest primarily in the Information Technology and Life Sciences sectors.
Although based in Europe, Index invests in a number of geographies including Europe, Eastern Europe and Russia, Israel, as well as New York City and Silicon Valley. The firm is considered  to have the investment philosophy of a typical Silicon Valley venture capitalist and to have unusually strong business relations in Silicon Valley for a European investor.
In 2007 Index ventures partner Danny Rimer was named to Forbes Magazine's Midas List of the world's 25 best deal makers in venture capital. Index partner Saul Klein is among the most active in the European entrepreneur community. Klein founded Seedcamp to help European entrepreneurs successfully build technology businesses, and also started The Accelerator Group (TAG) as a vehicle for investing in early-stage internet services, e-commerce and digital media businesses.
In March 2012, Index Ventures announced the launch of a $200 million life sciences fund, in partnership with Johnson and Johnson and GlaxoSmithKline. In March 2009, the firm announced the closing of a $455 million (€350 million) early stage fund, Index Ventures V. Before that, in January 2008, the firm announced the closing of a $577 million (€400 million) growth capital fund, Index Ventures Growth I, the firm's first dedicated late-stage growth fund.
The firm's partners include Ben Holmes, Bernard Dalle, Danny Rimer, David Rimer, Dominique Vidal, Francesco De Rubertis, Giuseppe Zocco, Michele Ollier, Mike Volpi, David Grainger, Neil Rimer, Saul Klein, and Robin Klein.
Among the firm's investments are the following:
- "Index Ventures Forth, Bridging Silicon Valley With Silicon Roundabout". TechCrunch. 30 November 2011.
- Drug Giants Back New Venture Capital Fund. New York Times Dealbook, March 21, 2012
- Drug Giants Back New Venture Capital Fund. TechCrunch, January 21, 2008
- "Portfolio". Index Ventures. Retrieved 14 May 2013.
- Christina Farr (16 October 2012). "With StorSimple acquisition, Microsoft turns up the heat on Rackspace, Amazon". Venture Beat. Retrieved 19 July 2013.
- Index Ventures (company website)